Zhang MJ - Search Results

1

CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.

Zhang MJ, Liu J, Wan SC, Li JX, Wang S, Fidele NB, Huang CF, Sun ZJ. Zhang MJ, et al. Head Neck. 2023 Sep;45(9):2161-2172. doi: 10.1002/hed.27464. Epub 2023 Jul 19. Head Neck. 2023. PMID: 37466293

2

LAIR-1 overexpression and correlation with advanced pathological grade and immune suppressive status in oral squamous cell carcinoma.

Yang LL, Zhang MJ, Wu L, Mao L, Chen L, Yu GT, Deng WW, Zhang WF, Liu B, Sun WK, Sun ZJ. Yang LL, et al. Among authors: zhang wf, zhang mj. Head Neck. 2019 Apr;41(4):1080-1086. doi: 10.1002/hed.25539. Epub 2018 Dec 14. Head Neck. 2019. PMID: 30549148

3

Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma.

Zhang MJ, Wu CC, Wang S, Yang LL, Sun ZJ. Zhang MJ, et al. Oral Dis. 2023 Jan;29(1):175-187. doi: 10.1111/odi.14045. Epub 2021 Oct 21. Oral Dis. 2023. PMID: 34651389

4

Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma.

Zhang MJ, Wang S, Wu CC, Wu L, Sun ZJ. Zhang MJ, et al. J Oral Pathol Med. 2022 Apr;51(4):379-387. doi: 10.1111/jop.13289. Epub 2022 Mar 9. J Oral Pathol Med. 2022. PMID: 35226778

5

Emerging Biomaterials Imaging Antitumor Immune Response.

Ma X, Zhang MJ, Wang J, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Ma X, et al. Among authors: zhang t, zhang mj. Adv Mater. 2022 Oct;34(42):e2204034. doi: 10.1002/adma.202204034. Epub 2022 Sep 18. Adv Mater. 2022. PMID: 35728795 Review.

6

Stepwise Size Shrinkage Cascade-Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis.

Liang MY, Zhang MJ, Qiu W, Xiao Y, Ye MJ, Xue P, Kang YJ, Sun ZJ, Xu Z. Liang MY, et al. Among authors: zhang mj. Adv Sci (Weinh). 2022 Sep;9(26):e2203353. doi: 10.1002/advs.202203353. Epub 2022 Jul 22. Adv Sci (Weinh). 2022. PMID: 35869614 Free PMC article.

7

Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.

Yang SC, Wang WY, Zhou JJ, Wu L, Zhang MJ, Yang QC, Deng WW, Sun ZJ. Yang SC, et al. Among authors: zhang mj. Int Immunopharmacol. 2022 Oct;111:109113. doi: 10.1016/j.intimp.2022.109113. Epub 2022 Aug 6. Int Immunopharmacol. 2022. PMID: 35944462

8

Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy.

Wan SC, Ye MJ, Yang QC, Zhang T, Zhang MJ, Ma XB, Xu JM, Wang S, Wu ZZ, Yang LL, Shen XM, Xu Z, Sun ZJ. Wan SC, et al. Among authors: zhang t, zhang mj. Adv Healthc Mater. 2023 Mar;12(7):e2202135. doi: 10.1002/adhm.202202135. Epub 2022 Dec 11. Adv Healthc Mater. 2023. PMID: 36479643

9

Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis.

Zhang MJ, Liang MY, Yang SC, Ma XB, Wan SC, Yang QC, Wang S, Xu Z, Sun ZJ. Zhang MJ, et al. Chem Commun (Camb). 2023 Jan 19;59(7):932-935. doi: 10.1039/d2cc05498a. Chem Commun (Camb). 2023. PMID: 36597866

10

CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.

Xiao Y, Mao L, Yang QC, Wang S, Wu ZZ, Wan SC, Zhang MJ, Sun ZJ. Xiao Y, et al. Among authors: zhang mj. Oral Oncol. 2023 Mar;138:106331. doi: 10.1016/j.oraloncology.2023.106331. Epub 2023 Feb 6. Oral Oncol. 2023. PMID: 36753904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

897 results

Search Page